Sanofi FCPA Settlement Follows Drought In Pharma Foreign Bribery Cases
Sanofi agrees to pay $25.2m to resolve charges its Kazakhstan and Middle East subsidiaries paid bribes to win business; last pharma settlements were in 2016.
You may also be interested in...
Revisions to DoJ guidelines will let companies off the hook for self-reported overseas bribery charges in many cases. But whether or not to come forward remains a tricky decision.
Teva made over $200 million in profits resulting from payments to government officials in Ukraine, Russia and Mexico; now it will have to pay $519M in civil and criminal penalties. J&J held the previous record for the pharma sector in FCPA penalties of $70m.
Pilot program from DOJ reduces fines for companies that voluntarily disclose misconduct; focus of investigations is broadening from sales to suppliers.